openPR Logo
Press release

Niemann Pick Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Orphazyme, Cyclo, Mandos, IntraBio, E-scape Bio, Synaptogenix, Evox, StrideBio, ENDECE, Oraxion, Polaryx

10-20-2023 04:26 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Niemann Pick Disease Pipeline Analysis (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Niemann Pick Disease therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Niemann Pick Disease Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Niemann Pick Disease Therapeutics Market.

The report provides a detailed description of the Niemann Pick Disease drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Niemann Pick Disease Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Niemann Pick Disease Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Niemann Pick Disease therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Niemann Pick Disease treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Niemann Pick Disease drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Niemann Pick Disease treatment market.

Learn More about the Clinical and Commercial Development Activities in the Niemann Pick Disease Therapeutics Domain @
https://www.delveinsight.com/report-store/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Niemann Pick Disease Therapeutics Analysis
There are approx. 20+ key companies developing the therapies for Niemann-Pick-Disease. Currently, Orphazyme is leading the therapeutics market with its Niemann-Pick-Disease drug candidates in the most advanced stage of clinical development.

Niemann Pick Disease Companies in the Therapeutics Market Include:
• Orphazyme
• Cyclo Therapeutics
• Mandos LLC
• IntraBio
• E-scape Bio
• Scenic Biotech
• Synaptogenix
• Evox Therapeutics
• StrideBio
• SOM Biotech
• ENDECE
• Oraxion Therapeutics
• Polaryx Therapeutics
And Many Others

Emerging and Marketed Niemann Pick Disease Therapies Covered in the Report Include:
• Arimoclomol: Orphazyme
• Trappsol Cyclo: Cyclo Therapeutics
• VTS-270: Mandos LLC
• ESB1609: E-scape Bio
And Many More

Get an in-depth Assessment of the Emerging Therapies and Niemann Pick Disease Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Niemann Pick Disease Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Niemann-Pick-Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Niemann Pick Disease Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Niemann Pick Disease Current Treatment Patterns
4. Niemann Pick Disease - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Niemann Pick Disease Late-Stage Products (Phase-III)
7. Niemann Pick Disease Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Niemann Pick Disease Discontinued Products
13. Niemann Pick Disease Product Profiles
14. Niemann Pick Disease Companies
15. Niemann Pick Disease Drugs
16. Dormant and Discontinued Products
17. Niemann Pick Disease Unmet Needs
18. Niemann Pick Disease Future Perspectives
19. Niemann Pick Disease Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Preeclampsia Market
https://www.delveinsight.com/report-store/preeclampsia-market

Chronic Periodontitis Market
https://www.delveinsight.com/report-store/chronic-periodontitis-market

Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market

Exocrine Pancreatic Insufficiency Market
https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-market

Papilloma MarketRespiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/respiratory-distress-syndrome-market

Sinusitis Market
https://www.delveinsight.com/report-store/sinusitis-market

Childhood Atropine For Myopia Progression Market
https://www.delveinsight.com/report-store/childhood-atropine-for-myopia-progression-market

Cushing's Syndrome Market
https://www.delveinsight.com/report-store/cushings-syndrome-market

Skin Burns Market
https://www.delveinsight.com/report-store/skin-burns-market

Adeno-Associated Virus Vectors in Gene Therapy Market
https://www.delveinsight.com/report-store/adeno-associated-virus-vectors-in-gene-therapy-market

Autism Spectrum Disorder Market
https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market

Fragile X Syndrome (FXS) Market
https://www.delveinsight.com/report-store/fragile-x-syndrome-fxs-market

Lymphedema Market
https://www.delveinsight.com/report-store/lymphedema-market

Optic Neuropathy Market
https://www.delveinsight.com/report-store/optic-neuropathy-market

Nicotine Addiction MarketDiverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Sinus Dilation Devices Market
https://www.delveinsight.com/report-store/sinus-dilation-devices-market

Von Willebrand disease (VWD) Market
https://www.delveinsight.com/report-store/von-willebrand-disease-vwd-market

Type 2 Diabetes Market
https://www.delveinsight.com/report-store/type-2-diabetes-market

Bone Resorption Market
https://www.delveinsight.com/report-store/bone-resorption-market

Peptic Ulcers Market
https://www.delveinsight.com/report-store/peptic-ulcers-market

Castration-Resistant Prostate Cancer (CRPC) Market
https://www.delveinsight.com/report-store/castration-resistant-prostate-cancer-crpc-market

Dysmenorrhea Market
https://www.delveinsight.com/report-store/dysmenorrhea-market

HDAC Inhibitors Market
https://www.delveinsight.com/report-store/hdac-inhibitors-market

Iron Deficiency Anemia Market
https://www.delveinsight.com/report-store/iron-deficiency-anemia-market

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market

Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market

Sacral Nerve Stimulator Devices Market
https://www.delveinsight.com/report-store/sacral-nerve-stimulator-devices-market

Graft Versus Host Disease Market
https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market

Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market

Artificial Disc Market
https://www.delveinsight.com/report-store/artificial-disc-market

Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market

Bone Neoplasms Market
https://www.delveinsight.com/report-store/bone-neoplasms-market

Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market

Secondary Hyperparathyroidism Market
https://www.delveinsight.com/report-store/secondary-hyperparathyroidism-market

Fetal Monitoring Devices Market
https://www.delveinsight.com/report-store/fetal-monitoring-devices-market

Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market

Interspinous Spacers Market
https://www.delveinsight.com/report-store/interspinous-spacers-market

Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market

Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market

Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market

Diabetic Peripheral Neuropathy Market
https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market

Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market

Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market

Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market

Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market

Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market

Prurigo Nodularis Market
https://www.delveinsight.com/report-store/prurigo-nodularis-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Niemann Pick Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Orphazyme, Cyclo, Mandos, IntraBio, E-scape Bio, Synaptogenix, Evox, StrideBio, ENDECE, Oraxion, Polaryx here

News-ID: 3258707 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and